Minoru Tobiume - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Minoru Tobiume

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Med (New York, N.Y.)|March 9, 2022

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variantsSho Miyamoto, Takeshi Arashiro, Yu Adachi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 22, 2023

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infectionSho Miyamoto, Takara Nishiyama, Akira Ueno, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severityChiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Med (New York, N.Y.)|March 9, 2022

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variantsSho Miyamoto, Takeshi Arashiro, Yu Adachi, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 22, 2023

Infectious virus shedding duration reflects secretory IgA antibody response latency after SARS-CoV-2 infectionSho Miyamoto, Takara Nishiyama, Akira Ueno, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 27, 2022

Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severityChiaki Iwamura, Kiyoshi Hirahara, Masahiro Kiuchi, et al.

Pageof 6